This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Regeneron – Regeneron slipped 5% after the pharmaceutical company said that sales of its Eylea drug were negatively impacted in the final quarter of 2022 by a shift to an off-label competitor. Monolithic Power Systems – Shares of Monolithic Power Systems gained 6.4% Oracle – Oracle advanced 2.6%
Fragile fiscal balances, ongoing external debt restructuring and high debt servicing costs. Since then, Rajapaksa’s successor, President Ranil Wickremesinghe has presided over yet another tentative economic recovery. Entrenched corruption and bureaucratic red tape. Excessive reliance on tourism and textiles.
The testimony also cited the FTC’s order against Herbalife, which had to restructure its business operations and pay $200 million to consumers it had deceived into believing they could earn substantial money selling diet and nutritional products. This year, the FTC brought a $100 million judgment against LifeLock.
Many of these companies may already be experiencing distress or working through restructuring strategies. percent), Technology and Telecommunication (6.9%) and Pharmaceuticals (6.3%). In the three-month period, the sectors with the highest proportion of zombies included Raw Materials (with 14.6% zombies), Biotechnology (12.6
Carrying this through to the real world, you should not be surprised to see technology and pharmaceutical companies, the two biggest spenders on R&D, report much higher accounting returns than they are actually earning on their investments.
In a report that it is required to file under the Hart-Scott-Rodino Act for the 2023 fiscal year, the DOJ listed out the number of merger challenges for the year (16), breaking them down into wins (1), consent agreements (4), ongoing litigation (1) and abandonments/restructured complaints (10).
We organize all of the trending information in your field so you don't have to. Join 39,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content